Description
Visprazole is a sterile intravenous formulation containing Pantoprazole Sodium BP 40mg, manufactured by ANVIS. It is indicated for short-term treatment of acid-related disorders such as gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, and erosive esophagitis, particularly when oral administration is not feasible. Pantoprazole is a proton pump inhibitor (PPI) that works by suppressing gastric acid secretion, providing rapid and sustained relief from symptoms of hyperacidity.
Each vial of Visprazole is sealed and packaged in a branded box with vibrant labeling for easy identification in hospital or clinical settings. Its IV-only formulation ensures fast delivery and bioavailability, making it suitable for acute therapeutic management in adult patients.
